Catalyst
Slingshot members are tracking this event:
Protalix BioTherapeutics Announces First Patient Dosed in the AIR DNase Phase II Clinical Trial for Cystic Fibrosis
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| PLX |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 07, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Cystic Fibrosis, Air Dnase, Phase Ii Clinical Trial, Human Deoxyribonuclease I, Pulmozyme, Forced Vital Capacity, I-neb Aad Inhaler System, Ultrasonic Nebulizers, Fabry Disease, Prx-102
